Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02700880 · ClinicalTrials.gov registry record
LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
A clinical trial, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- 250
- Enrollment target
NCT02700880 is a clinical trial that has completed, run by Zoll Medical Corporation. The registered enrollment target is 250 participants.
The verdict
NCT02700880 has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The WEARIT-III registry enrolls subjects with ischemic cardiomyopathy and heart failure (including NYHA II, III, IV and an ejection fraction ≤ 35%) who wear a medically prescribed ZOLL LifeVest Wearable Defibrillator. The primary objective of the WEARIT-III Registry is to prospectively document the clinical course of high-risk cardiac patients with heart failure and ischemic cardiomyopathy prescribed with Wearable Cardioverter Defibrillator (WCD), such as left ventricular function recovery, arrhythmia, Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT), Left Ventricular Assist Device (LVAD), heart transplantation, and to assess the benefit of WCD in heart failure patients with ischemic cardiomyopathy.
Interventions
- DEVICE LifeVest
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2014-06 |
| Est. Completion | 2019-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02700880
The ClinicalTrials.gov registry entry for NCT02700880 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LifeVest is the first listed.
NCT02700880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02700880 about?
NCT02700880 is a clinical study titled "LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry". The WEARIT-III registry enrolls subjects with ischemic cardiomyopathy and heart failure (including NYHA II, III, IV and an ejection fraction ≤ 35%) who wear a medically prescribed ZOLL LifeVest Wearable Defibrillator. The primary objective of the WEARIT-III Registry is to prospectively document the ...
What is the current status of trial NCT02700880?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2014-06. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02700880?
The interventions under investigation include: LifeVest (DEVICE).
Who is sponsoring clinical trial NCT02700880?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.